Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

PtdIns-4,5-P2 as a potential therapeutic target for pathologic angiogenesis.

PtdIns-4,5-P2 as a potential therapeutic target for pathologic angiogenesis. Expert Opin Ther Targets. 2007 Apr; 11(4):443-51.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.